Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-11-28

Clinical Trial Update: SThe Effects of Melatonin on GERD Symptoms [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update examining the effects of melatonin on gastroesophageal reflux disease symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Gastroesophageal Reflux Disease | Phase 1, Phase 2 | Status: UNKNOWN